Diabetic Support Group Meeting August 19
The Diabetic Support Group will meet on Thursday, August 19 at 7 pm at the Carilion Stonewall Jackson Hospital conference room A. Paul Biggio will make a presentation on Sleep Apnea. The meeting if free and open to the public.
Fri, 30 Jul 2010 09:11:22 -0700
Increase Circulation and Prevent Varicose Veins with New Diabetic Socks
There is a new prevention method people can reduce the chance of having varicose veins. Utilizing non-binding or diabetic socks eliminates the sock ring imprint normal socks leave behind, which increases blood flow. Though the blood restriction is small, the accumulative affect is great. There are a two types of health socks that can be incorporated into daily use to reduce chances of varicose ...
Sat, 31 Jul 2010 00:05:00 -0700
Diabetic meal on trains
The railways will serve diabetic meals on long-distance trains, starting with the Howrah Rajdhani Express and the Howrah-Delhi Duronto Express. Derek OBrien, the chairman of the passengers services committee of the railways, said the service would be launched by Puja.
Mon, 26 Jul 2010 14:04:29 -0700
Study suggests physicians to individualize blood sugar targets for diabetic hemodialysis patients
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population.
Fri, 30 Jul 2010 02:07:28 -0700
Will County search for blind diabetic man
Authorities in Will County searched Wednesday for a missing blind diabetic man who threatened to harm himself, a sheriff's spokesman said. Family members of Anthony Thompson, 54, reported him missing from an unincorporated area of Will County near Peotone about two and a half hours after he disappeared this morning, said Will County Sheriff's Department spokesman Pat Barry. Before his ...
Wed, 28 Jul 2010 20:37:16 -0700
Just Drop It: The One-Size-Fits-All Approach To Blood Sugar Control, That Is
Individualized care necessary for diabetic patients with kidney failureAggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely ...
Fri, 30 Jul 2010 15:16:06 -0700
Diabetic Man, 67, Missing In Ormond Beach
Ormond Beach police are asking for the public's help in locating a 67-year-old man missing since at least 7 a.m. Wednesday.
Wed, 28 Jul 2010 07:53:20 -0700
The Mystery Of Healthy Fat People
Why some obese people go on to become diabetic while others do not. It is common to find obese people even morbidly obese people who are healthier than their condition would normally allow. Working with subjects with a body mass index of about 56, a team of researchers in Spain and Cambridge investigated the inflammatory and insulin signalling pathways in the patients' visceral adipose tissue ...
Sat, 31 Jul 2010 04:36:51 -0700
Human insulin-producing beta cell replication sustained with single stimulatory molecule: Study
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.
Wed, 28 Jul 2010 03:05:36 -0700
Human insulin-producing beta cell replication sustained with single stimulatory molecule: Study
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.
Wed, 28 Jul 2010 03:05:36 -0700
One Molecule, Many More Insulin-Producing Cells To Treat Diabetes
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.They also found several cocktails of molecules that drive human beta cells to replicate, as well as important ...
Wed, 28 Jul 2010 13:03:34 -0700
One Molecule, Many More Insulin-Producing Cells To Treat Diabetes
With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.They also found several cocktails of molecules that drive human beta cells to replicate, as well as important ...
Wed, 28 Jul 2010 13:03:34 -0700
One molecule, many more insulin-producing cells to treat diabetes, says Pitt team
( University of Pittsburgh Schools of the Health Sciences ) With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes. They also found several cocktails of molecules that drive human beta cells to replicate, as well ...
Tue, 27 Jul 2010 21:16:34 -0700
One molecule, many more insulin-producing cells to treat diabetes, says Pitt team
( University of Pittsburgh Schools of the Health Sciences ) With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes. They also found several cocktails of molecules that drive human beta cells to replicate, as well ...
Tue, 27 Jul 2010 21:16:34 -0700
Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has now achieved 75% of the required number of per-protocol completers in its ongoing six month pivotal global Phase III study of Generex Oral-lyn, the Company's proprietary buccal insulin spray product.
Wed, 28 Jul 2010 23:35:16 -0700
Generex reports positive trends in ongoing Oral-lyn buccal insulin spray global Phase III trial
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has now achieved 75% of the required number of per-protocol completers in its ongoing six month pivotal global Phase III study of Generex Oral-lyn, the Company's proprietary buccal insulin spray product.
Wed, 28 Jul 2010 23:35:16 -0700
Calibra Gains FDA Clearance To Market Finesse Insulin Patch-Pen For Three-Day Use With Novolog®
Calibra Medical announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small ...
Tue, 27 Jul 2010 05:12:18 -0700
Calibra Gains FDA Clearance To Market Finesse Insulin Patch-Pen For Three-Day Use With Novolog®
Calibra Medical announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small ...
Tue, 27 Jul 2010 05:12:18 -0700
The Mystery Of Healthy Fat People
Why some obese people go on to become diabetic while others do not. It is common to find obese people even morbidly obese people who are healthier than their condition would normally allow. Working with subjects with a body mass index of about 56, a team of researchers in Spain and Cambridge investigated the inflammatory and insulin signalling pathways in the patients' visceral adipose tissue ...
Sat, 31 Jul 2010 04:36:51 -0700
The Mystery Of Healthy Fat People
Why some obese people go on to become diabetic while others do not. It is common to find obese people even morbidly obese people who are healthier than their condition would normally allow. Working with subjects with a body mass index of about 56, a team of researchers in Spain and Cambridge investigated the inflammatory and insulin signalling pathways in the patients' visceral adipose tissue ...
Sat, 31 Jul 2010 04:36:51 -0700
A look inside the government's deportation flights
Guillermo Campos Ojeda stares blankly at the clouds from the jetliner's window, mentally retracing the 22 years that he lived in the United States as an illegal immigrant.
Sat, 31 Jul 2010 17:22:54 -0700
A look inside the government's deportation flights
Guillermo Campos Ojeda stares blankly at the clouds from the jetliner's window, mentally retracing the 22 years that he lived in the United States as an illegal immigrant.
Sat, 31 Jul 2010 17:22:54 -0700
Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog
Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a ...
Mon, 26 Jul 2010 07:05:06 -0700
Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog
Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a ...
Mon, 26 Jul 2010 07:05:06 -0700
Foods That Fight Breast Cancer?
Take a look at some of the foods -- including onions and walnuts -- that might help people fight breast cancer.
Sat, 31 Jul 2010 16:18:13 -0700
Foods That Fight Breast Cancer?
Take a look at some of the foods -- including onions and walnuts -- that might help people fight breast cancer.
Sat, 31 Jul 2010 16:18:13 -0700
Copyright 2008 - All Rights Reserved - www.living-with-diabetes.info
